This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Jul;68(1):59-60.

doi: 10.1016/j.eururo.2015.01.006. Epub 2015 Mar 23.

Life Expectancy and Treatment Choice for Men with High-risk Prostate Cancer

Timothy J Daskivich¹

Affiliations

Affiliation

¹ Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: tdaskivich@ucla.edu.

PMID: 25813689
DOI: 10.1016/j.eururo.2015.01.006

Editorial

Life Expectancy and Treatment Choice for Men with High-risk Prostate Cancer

Timothy J Daskivich. Eur Urol. 2015 Jul.

. 2015 Jul;68(1):59-60.

doi: 10.1016/j.eururo.2015.01.006. Epub 2015 Mar 23.

Author

Timothy J Daskivich¹

Affiliation

¹ Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: tdaskivich@ucla.edu.

PMID: 25813689
DOI: 10.1016/j.eururo.2015.01.006

No abstract available

PubMed Disclaimer

Comment on

Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O, Folkvaljon Y, Hjälm Eriksson M, Akre O, Carlsson S, Drevin L, Franck Lissbrant I, Makarov D, Loeb S, Stattin P. Bratt O, et al. Eur Urol. 2015 Jul;68(1):53-8. doi: 10.1016/j.eururo.2014.12.026. Epub 2015 Mar 23. Eur Urol. 2015. PMID: 25813688

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information